Wednesday, September 09, 2009 11:35:30 AM
I suspect that we might hear significantly more about the company's mindset on this at the investor conference later today.
And, to be honest about this... we knew last year that management wasn't opposed to the reverse stock split idea. It was brought up I think as a 'possibility' if there was a good enough reason.
My guess is, they may be getting inquiries from people who cannot invest in the company until the pps and listing issues are resolved.
So, the only way to do this is the split or to flat out sell the company to a listed company. I'd rather have the split then be a pimple on some big Pharma's butt.
And, to be honest about this... we knew last year that management wasn't opposed to the reverse stock split idea. It was brought up I think as a 'possibility' if there was a good enough reason.
My guess is, they may be getting inquiries from people who cannot invest in the company until the pps and listing issues are resolved.
So, the only way to do this is the split or to flat out sell the company to a listed company. I'd rather have the split then be a pimple on some big Pharma's butt.
Recent TENX News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/02/2026 04:15:29 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/24/2026 03:41:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/10/2026 11:48:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 11:32:44 AM
- Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/10/2026 11:00:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/09/2026 04:24:22 PM
- Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference • GlobeNewswire Inc. • 03/03/2026 12:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/12/2026 06:21:10 PM
- Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 • GlobeNewswire Inc. • 02/04/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:49:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:14:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 01:46:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 01:29:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 01:03:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 12:53:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2026 09:33:28 PM
